Urolithin A alleviates neuropathic pain and activates mitophagy.

Abstract

Neuropathic pain (NP) occurs frequently in the general population and has a negative impact on the quality of life. There is no effective therapy available yet owing to the complex pathophysiology of NP. In our previous study, we found that urolithin A (UA), a naturally occurring microflora-derived metabolite, could relieve NP in mice by inhibiting the activation of microglia and release of inflammation factors. Here in this study, we sought to investigate whether mitophagy would be activated when UA alleviated NP in mice. We showed that the autophagy flow was blocked in the spinal dorsal horn of the chronic constriction injury (CCI) mice when the most obvious pain behavior occurs. Intraperitoneal injection of UA markedly activated the mitophagy mediated by PTEN-induced kinase 1/Parkin, promoted mitobiogenesis in both neurons and microglia, and alleviated NP in the CCI mice. In summary, our data suggest that UA alleviates NP in mice and meanwhile induces mitophagy activation, which highlights a therapeutic potential of UA in the treatment of NP.

• Authors: Chenyi Wang, Zizhu Wang, Shiyu Xue, Yutong Zhu, Jiahao Jin, Qiuyu Ren, Xiaodong Shi
• Journal: Molecular pain (Mol Pain) 2023 Jan-Dec Vol. 19 Pg. 17448069231190815 ISSN: 1744-8069 [Electronic] United States
• PMID: 37464536 (Publication Type: Journal Article)

Chemical References

• 3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one

Topics

• Humans
• Mice
• Animals
• Mitophagy (physiology)
• Quality of Life
• Spinal Cord Dorsal Horn (metabolism)
• Neuralgia (metabolism)